Alpharma To Pay $42.5M Over Morphine Marketing
Pharmaceutical giant Alpharma Inc. has agreed to fork over $42.5 million to resolve allegations that it paid health care providers to promote its morphine-based drug Kadian and misrepresented the medicine's safety....To view the full article, register now.
Already a subscriber? Click here to view full article